To validate the relationship between SOD2 and pancreatic cancer development in vivo, immunohistochemistry (IHC) analyses for proliferation (pmTOR), EMT (E-cadherin), and apoptosis marker (cleaved caspase 9) were assessed on xenograft tumor tissues (Figure 7I). The gene discussed is SOD2; the disease is neoplasm.